| Zeng, Yong |
TCTN, NCT02455141: Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer |
|
|
| Recruiting | 3 | 970 | RoW | Epirubicin plus Cyclophosphamide, EC, Taxanes, Taxanes plus Carboplatin | Shanghai Jiao Tong University School of Medicine | Breast Neoplasm | 12/22 | 12/23 | | |
NCT06349317: Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT |
|
|
| Recruiting | 2 | 33 | RoW | Neoadjuvant intensity-modulated radiotherapy combined with perioperative camrelizumab and apatinib | Yongyi Zeng | Hepatocellular Carcinoma | 05/26 | 06/26 | | |
SUPERIOR, NCT04617899: The StUdy to Evaluate the Performance and safEty of the Novasight HybRid System Using Objective PeRformance Criteria |
|
|
| Recruiting | N/A | 120 | RoW | Intravascular imaging | CardioNavi MedTech (Wuhan) Co., Ltd., Beijing Jingruitianhe Medical Science and Technology Development Co,Ltd | Coronary Artery Disease | 11/21 | 12/21 | | |
NCT04953117: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease |
|
|
| Recruiting | N/A | 286 | RoW | DCB of Lepu Medical(dimeter≥2.00 mm), Coronary Drug Coated Balloon Catheter of Lepu Medical for coronary small vessels, Restore DEB, RESTORE Paclitaxel releasing coronary balloon catheter, DCB of Lepu Medical(dimeter<2.00 mm), Coronary Drug Coated Balloon Catheter of Lepu Medical for coronary very small vessels | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease | 06/22 | 04/23 | | |
| Completed | N/A | 1556 | RoW | | Beijing Anzhen Hospital, Beijing Life oasis public service center | Angina Pectoris, Real World Study | 06/23 | 06/23 | | |
NCT06102226: Deep Learning Algorithm for Detecting Obstructive Coronary Artery Disease Using Fundus Photographs |
|
|
| Recruiting | N/A | 7000 | RoW | coronary artery imaging (coronary CTA or coronary angiography) | Yong Zeng | Coronary Artery Disease, Artificial Heart Device User | 08/24 | 12/24 | | |
| Not yet recruiting | N/A | 500 | RoW | Assessment of plaque morphology, structure, and stability in non-culprit lesions | Chinese PLA General Hospital | Coronary Arterial Disease (CAD), Acute Coronary Syndromes | 12/27 | 12/31 | | |
COG-T CHD, NCT05735041: Computerized Cognitive Training in Patients With Coronary Heart Disease and Mild Cognitive Impairment |
|
|
| Active, not recruiting | N/A | 224 | RoW | Multi-domain cognitive digital therapy, Basic cognitive therapy | Beijing Anzhen Hospital, Beijing Wispirit Technology Co., Ltd | Mild Cognitive Impairment, Coronary Heart Disease | 12/24 | 07/25 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
